1. Home
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Immunofluorescence Assay Global Market Report 2022

Immunofluorescence Assay Global Market Report 2022

  • September 2022
  • 175 pages
  • ID: 6318511
  • Format: PDF
  • The Business Research Company

Summary

Table of Contents

Major players in the immunofluorescence assay market are Thermo Fisher Scientific, Inc., Abcam plc, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Agilent Technologies, Becton Dickinson and Company, Maxvision Biosciences Inc., Zyagen, J. Mitra & Co. Pvt. Ltd., AESKU GROUP GmbH, Vector Laboratories, Inc., EpiGentek Group, and Elabscience, Inc.

The global immunofluorescence assay market is expected to grow from $2.71 billion in 2021 to $2.90 billion in 2022 at a compound annual growth rate (CAGR) of 6.93%. The immunofluorescence assay market is expected to grow to $3.68 billion in 2026 at a compound annual growth rate (CAGR) of 6.14%.
The immunofluorescence assay market consists of sales of immunofluorescence assay and related products by entities (organizations, sole traders, partnerships) that refer to equipment and consumables that operate on a technique, which allows the visualization of specific protein and antigen in infected cells based on their ability to react with specific antibodies by binding a particular antibody chemically conjugated with a fluorescent dye. It is a technique used in the laboratory to diagnose diseases of the skin, kidney, heart, cilia, and other organ systems.

The main types of immunofluorescence assay include direct immunofluorescence and indirect immunofluorescence.Direct immunofluorescence refers to a laboratory technique for diagnosing skin, kidney, and other organ system diseases.

Direct immunofluorescence utilizes a single antibody that is conjugated directly to fluorescence dye.The different products of immunofluorescence assay include reagents, instruments, antibodies, kits, consumables & accessories.

They are used for the diagnosis of various diseases including cancer, infectious disease, autoimmune disease, and others. They are used by academic and research institutions, pharmaceutical and biotechnology companies, hospitals & diagnostic centres, and contract research organizations.

North America was the largest region in the immunofluorescence assay market in 2021, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the immunofluorescence assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The immunofluorescence assay market research report is one of a series of new reports that provides immunofluorescence assay market statistics, including immunofluorescence assay industry global market size, regional shares, competitors with an immunofluorescence assay market share, detailed immunofluorescence assay market segments, market trends and opportunities, and any further data you may need to thrive in the immunofluorescence assay industry. This immunofluorescence assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The increasing prevalence of chronic diseases is significantly driving the growth of the immunofluorescence assay market.The changing lifestyle, dietary habits, and improper weight management are contributing to the rapid growth in chronic conditions and a few prolonged chronic infections are leading to cancerous risk.

The growing prevalence of chronic disease is expected to boost demand for immunofluorescence assays as they are widely used in diagnosis and drug development activities. For instance, according to the study published by the Centers for Disease Control and Prevention, approximately 6 in 10 adults in the USA are affected by chronic disease, and it is also accounting for $3.8 trillion in annual healthcare costs. Therefore, the increasing prevalence of chronic diseases is expected to boost demand for immunofluorescence assay during forecast period.

Technological advancement is a key trend gaining popularity in the immunofluorescence assay market.The companies operating in immunofluorescence assay are focusing on developing technologically innovative products to meet specific technical demands for the diagnostic of new viruses such as COVID-19 and strengthen their market position.

For instance, in March 2022, LumiraDx, a UK-based developer of point-of-care diagnostics, received emergency approval for LumiraDx SARS-CoV-2 Ag Test, a microfluidic immunofluorescence assay, designed for qualitative nucleocapsid protein antigen detection from nasal swab samples.

In July 2019, AESKU Group, a Germany-based, developer of rapid test systems for blood diagnostics and immunoassays, acquired MBL Bion for an undisclosed amount.With this acquisition, AESKU is focused on reducing its order processing and delivery times.

Additionally, the high-quality MBLBion HEp-2 cells and extensive infectious disease testing slides, add tremendous value to AESKU’s new HELIOS ’HTC’ humidity and temperature control module. MBL Bion is a US-based manufacturer of high-quality IFA products for clinical laboratories.

The countries covered in the immunofluorescence assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Specialty Generics Global Market Report 2022: Ukraine-Russia War Impact

  • $ 5000
  • December 2022
  • 175 pages

Major players in the specialty generics market are Teva Pharmaceutical Industries Ltd, Endo International plc, Akorn Operating Company LLC , Mylan N.V., Mallinckrodt Pharmaceuticals, Sandoz, Pfizer Inc, ...

  • World
  • United States
  • Chronic Disease
  • Industry analysis
  • Chronic Disease Prevalence
  • Generic Drugs Market Share

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on